Table 1 Basic clinical information of the RA population
Total(N = 418) | CVD(N = 173) | Non-CVD(N = 245) | P values△ | |
|---|---|---|---|---|
Sex [male, N (%)] | 106 (25.4) | 48 (27.7) | 58 (23.7) | 0.363 |
Age (years) | 54.44 ± 13.09 | 60.44 ± 9.88 | 50.20 ± 13.43 | < 0.001 |
BMI (Kg/m2) | 23.22 ± 3.86 | 23.87 ± 4.45 | 22.76 ± 3.31 | 0.004 |
CVD to Classify [N (%)] | ||||
CHD | 40 (9.6) | 40 (23.1) | 0 | |
Hypertension | 126 (30.1) | 126 (72.8) | 0 | |
Arrhythmia | 61 (14.6) | 61 (35.3) | 0 | |
HF | 4 (1.0) | 4 (2.3) | 0 | |
Low-physical activity [N (%)] | 61 (14.6) | 44 (25.4) | 17 (6.9) | < 0.001 |
Alcohol consumption [N (%)] | 10 (2.4) | 7 (4.0) | 3 (1.2) | 0.100 |
Somking [N (%)] | 72 (17.2) | 35 (20.2) | 37 (15.1) | 0.171 |
Duration of RA (years) | 5.00 (1.00,10.00) | 6.00 (1.50,15.00) | 4.00 (1.00,10.00) | 0.011 |
TyG index | 8.40 ± 0.63 | 8.48 ± 0.59 | 8.34 ± 0.66 | 0.030 |
RF (IU/mL) | 69.50(20.00,214.50) | 88.10(20.00,431.25) | 59.00(20.00,166.50) | 0.007 |
ESR (mm/h) | 35.22 ± 28.26 | 35.19 ± 28.58 | 35.24 ± 28.10 | 0.987 |
CRP (mg/dL) | 1.04(0.39,2.67) | 1.02(0.37,2.48) | 1.04(0.39,2.74) | 0.997 |
Anti-CCP Antibody (U/mL) | 472.00(25.00,1491.00) | 567.00(0,2274.00) | 383.00(32.50.1283.50) | 0.189 |
Immunoglobulin IgG (mg/dL) | 1367.55 ± 411.41 | 1346.54 ± 436.07 | 1382.35 ± 393.42 | 0.394 |
Complement C3 (mg/dL) | 94.16 ± 21.33 | 93.34 ± 20.27 | 94.74 ± 22.08 | 0.522 |
Complement C4 (mg/dL) | 20.40 ± 6.73 | 20.37 ± 6.49 | 20.43 ± 6.91 | 0.923 |
Hs-CRP (mg/L) | 8.34(2.67,22.87) | 8.29(2.70,21.15) | 8.65(2.58,22.91) | 0.897 |
Hcy (μmol/L) | 12.75 ± 6.76 | 13.86 ± 8.79 | 11.86 ± 4.37 | 0.010 |
LDL-C (mmol/L) | 2.68 ± 0.77 | 2.65 ± 0.79 | 2.71 ± 0.75 | 0.474 |
Ua (μmol/L) | 268.93 ± 86.17 | 280.94 ± 93.39 | 260.42 ± 79.78 | 0.017 |
QTc Interval (ms) | 427.30 ± 26.86 | 428.51 ± 30.74 | 426.43 ± 23.75 | 0.447 |
LVMI (g/m2) | 79.68 ± 22.05 | 84.68 ± 24.34 | 74.01 ± 17.62 | 0.001 |
BNP (pg/mL) | 43.95(22.80,80.18) | 53.20(28.50,112.60) | 40.60(19.10,67.00) | 0.054 |